443 related articles for article (PubMed ID: 16859810)
21. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center.
Filozov A; Visintainer P; Carbonaro C; Aguero-Rosenfeld M; Wormser GP; Montecalvo MA
Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935
[TBL] [Abstract][Full Text] [Related]
24. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
25. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
[TBL] [Abstract][Full Text] [Related]
26. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.
Demir S; Soysal A; Bakir M; Kaufmann ME; Yagci A
J Paediatr Child Health; 2008 Oct; 44(10):548-53. PubMed ID: 18557808
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Ena J; Arjona F; Martínez-Peinado C; López-Perezagua Mdel M; Amador C
Urology; 2006 Dec; 68(6):1169-74. PubMed ID: 17169640
[TBL] [Abstract][Full Text] [Related]
28. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
Nasa P; Juneja D; Singh O; Dang R; Singh A
Eur J Intern Med; 2012 Mar; 23(2):192-5. PubMed ID: 22284253
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
[TBL] [Abstract][Full Text] [Related]
30. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
31. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
Memon JI; Rehmani RS; Ahmed MU; Elgendy AM; Nizami IY
Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164
[TBL] [Abstract][Full Text] [Related]
32. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
Wener KM; Schechner V; Gold HS; Wright SB; Carmeli Y
Antimicrob Agents Chemother; 2010 May; 54(5):2010-6. PubMed ID: 20211888
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Lautenbach E; Strom BL; Bilker WB; Patel JB; Edelstein PH; Fishman NO
Clin Infect Dis; 2001 Oct; 33(8):1288-94. PubMed ID: 11565067
[TBL] [Abstract][Full Text] [Related]
35. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Schwaber MJ; Navon-Venezia S; Kaye KS; Ben-Ami R; Schwartz D; Carmeli Y
Antimicrob Agents Chemother; 2006 Apr; 50(4):1257-62. PubMed ID: 16569837
[TBL] [Abstract][Full Text] [Related]
36. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.
Hyle EP; Lipworth AD; Zaoutis TE; Nachamkin I; Bilker WB; Lautenbach E
Arch Intern Med; 2005 Jun; 165(12):1375-80. PubMed ID: 15983286
[TBL] [Abstract][Full Text] [Related]
37. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
[TBL] [Abstract][Full Text] [Related]
38. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
[TBL] [Abstract][Full Text] [Related]
40. Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China.
Hu B; Ye H; Xu Y; Ni Y; Hu Y; Yu Y; Huang Z; Ma L
Curr Med Res Opin; 2010 Jun; 26(6):1443-9. PubMed ID: 20394469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
